# China NMPA Drug Inspection - Shenzhen Jiurui Health Technology Development Co., Ltd.; Contractor: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd. - Jade Screen Granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shenzhen-jiurui-health-technology-development-co-ltd-contractor-sinopharm-group-guangdong-global-pharmaceutical-co-ltd/2cf4c084-759b-41cc-b1f5-0d8ac5d3d60b/
Source feed: China

> China NMPA drug inspection for Shenzhen Jiurui Health Technology Development Co., Ltd.; Contractor: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd. published October 29, 2021. Drug: Jade Screen Granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: The Yunnan Provincial Drug Administration issued the third issue of its 2021 Drug Quality Bulletin.
- Company Name: Shenzhen Jiurui Health Technology Development Co., Ltd.; Contractor: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd.
- Publication Date: 2021-10-29
- Drug Name: Jade Screen Granules
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/shenzhen-jiurui-health-technology-development-co-ltd-contractor-sinopharm-group-guangdong-global-pharmaceutical-co-ltd/434a62b7-23c0-4f26-a193-50250d822ee3/